Detalhe da pesquisa
1.
Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients.
Am J Respir Crit Care Med
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668710
2.
Bronchiectasis management in adults: state of the art and future directions.
Eur Respir J
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782469
3.
Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study.
Pulm Pharmacol Ther
; 83: 102260, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741357
4.
The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort.
BMC Infect Dis
; 22(1): 75, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062891
5.
Common Variable Immunodeficiency and Other Immunodeficiency Syndromes in Bronchiectasis.
Semin Respir Crit Care Med
; 42(4): 525-536, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261177
6.
The Impact of Tobacco Smoking in Bronchiectasis: Data from the United States Bronchiectasis and NTM Research Registry.
Am J Respir Crit Care Med
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712994
7.
Mind the gap: challenges to overcome in airway clearance.
Eur Respir J
; 63(6)2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843939
8.
Precision Endotyping in Bronchiectasis.
Am J Respir Crit Care Med
; 208(11): 1147-1148, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917354
9.
Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug-device combination.
Pulm Pharmacol Ther
; 50: 72-79, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29621625
10.
A New Bronchiectasis Endophenotype: Immunoallertypes.
Am J Respir Crit Care Med
; 199(7): 811-812, 2019 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30359084
11.
Non-cystic fibrosis bronchiectasis.
Am J Respir Crit Care Med
; 188(6): 647-56, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23898922
12.
Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation.
Tuberculosis (Edinb)
; 147: 102519, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754247
13.
Impact of the lung allocation score.
Semin Respir Crit Care Med
; 34(3): 275-80, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23821502
14.
Investigation and Management of Bronchiectasis in Nontuberculous Mycobacterial Pulmonary Disease.
Clin Chest Med
; 44(4): 731-742, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890912
15.
Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.
Int J Antimicrob Agents
; 62(1): 106847, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37187338
16.
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf.
ERJ Open Res
; 9(3)2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37465817
17.
Stenotrophomonas maltophilia in patients with bronchiectasis: An analysis of the US bronchiectasis and NTM Research Registry.
Respir Med
; 193: 106746, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124355
18.
An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease.
J Glob Antimicrob Resist
; 28: 71-77, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933140
19.
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study.
Respir Med
; 177: 106285, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33401148
20.
Nutrition and Markers of Disease Severity in Patients With Bronchiectasis.
Chronic Obstr Pulm Dis
; 7(4): 390-403, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108111